Watch video to learn more about Thousand Oaks Biopharmaceuticals

Intergrated CMC Solution

As a comprehensive CDMO engaged in both process development and customized manufacturing, it helps partners jointly advance the production of pre-clinical, clinical and commercial biologics.


Thousand Oaks Biopharmaceuticals has a powerful technical platform and state-of-the-art facilities to meet the ever-increasing demand of customers.

Facilities-Cell culture media

Since 2011, JSBiosciences has successively founded the Lanzhou Phase I and Nantong Phase II serum-free dry powder media bases, as well as the R&D centers in Shanghai and San Francisco, USA, to continue to reinforce its leading position in the industry.

Therapeutic biological products

Thousand Oaks Biopharmaceuticals provides one-stop pharmaceutical CMC solutions, ranging from cell line development to process development, IND application and clinical sample production, as well as BLA and commercial production services. It provides customers with full CDMO services from DNA sequence to drug commercialization.

Preventive biological products

The group provides full services for veterinary/human vaccine products from cell culture media, process development, to contract processing and manufacturing.

Quality & Regulatory

Thousand Oaks Biopharmaceuticals is committed to providing higher-quality and more affordable biologics to patients around the world. To respect the life of patients is the value that every employee at Thousand Oaks Biopharmaceuticals (Nantong) upholds. We strive to continuously promote the quality of products in order to improve the quality of human life.